Single Dose Pharmacokinetics of Intranasal Azelastine Delivered by a Fixed Combination With Fluticasone in Comparison to Azelastine Nasal Sprays Single-centre, Randomised, Open-label, Three-period, Six-sequence Cross-over Trial (William's Design)

Trial Profile

Single Dose Pharmacokinetics of Intranasal Azelastine Delivered by a Fixed Combination With Fluticasone in Comparison to Azelastine Nasal Sprays Single-centre, Randomised, Open-label, Three-period, Six-sequence Cross-over Trial (William's Design)

Completed
Phase of Trial: Phase I

Latest Information Update: 29 Apr 2016

At a glance

  • Drugs Azelastine/fluticasone-propionate (Primary) ; Azelastine
  • Indications Allergic rhinitis; Rhinitis; Seasonal allergic rhinitis
  • Focus Pharmacokinetics
  • Sponsors Meda Pharma GmbH & Co KG
  • Most Recent Events

    • 22 Feb 2012 Results published in the British Journal of Clinical Pharmacology.
    • 07 Dec 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 08 Sep 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top